Meta Connect Spotlights Camera-Free Smart Glasses Amid Privacy Concerns 
China Reviews Broadcom Switch Use in State Data Centres 
Paramount-Warner Bros $110 Billion Deal Draws Antitrust Backlash 
fnny Beta Launches With a Simple Idea: Find an Event, Show Up, Get Rewarded 
Novo Nordisk Weighs Direct NYSE Listing to Boost U.S. Profile 
SoftBank Launches $11 Billion Bond Sale to Fund OpenAI Investment 
China Vanke Shares Jump as Beijing Moves to Ease Debt Pressure 
H&M Q3 Profit Beats Estimates as Margins Improve 
Telix to Acquire Germany’s ITM in $1.65 Billion Radiopharma Deal 
JPMorgan Names Lavatelli Japan Chief in Leadership Shake-Up 
OpenAI Urges US-Led Global Standards for Frontier AI 
Meta Unveils Muse Charm AI Device, Expands Smart Glasses Lineup 
Trump Plans Federal AI Force and AI Czar 
Petrobras Joins Brazil’s New Diesel Subsidy Program 
Prysmian, Rio Tinto Supply Low-Carbon Cables for Amazon Ohio Data Center 
Paramount Skydance Faces $30 Million Film Penalty in Warner Bros. Deal 
Add as a preferred source on Google
Sanofi, the French pharmaceutical company, will be helping Moderna with the production of COVID-19 vaccines. The move was made in an effort to allow the American pharmaceutical and biotechnology firm to fulfill its orders and meet the demand for its shots.
Sanofi confirms production of Moderna shots
On Monday, April 26, Sanofi said that it has joined hands with the Massachusetts-headquartered biotech firm so it can provide assistance with filling vials and finish the packaging of up to 200 million doses as the demand for the Moderna COVID-19 vaccine is high.
Sanofi will be manufacturing the shots in its facility in Ridgefield, New Jersey. While the French company shared some info about its latest partnership with Moderna, it did not disclose any detail regarding the financial aspect of their deal, as per CNBC.
This is the third contract that Sanofi was able to secure since the start of this year. It previously signed a deal with Pfizer/BioNTech, to help them with supplying more than 125 million doses of coronavirus shots. The company also pledged to complete the filling and packing of Johnson & Johnson vaccines, and it must churn out at least 12 million doses per month.
Sanofi’s contribution in fulfilling Moderna’s COVID-19 vaccine supply will begin in September. While it has many deals to work on, the company is also busy in the development of its own vaccines in partnership with GlaxoSmithKline and another one with Translate Bio.
Sanofi aims to fill the bill for vaccines in the U.S.
The Wall Street Journal reported that based on the info coming from Sanofi’s spokesman, the finished doses of Moderna vaccines are for the U.S. supply where Moderna has an agreement until April 2022.
Meanwhile, Novartis AG and Merck Co. are also helping other makers of the coronavirus vaccines by forming agreements for production. The collaborations among the manufacturers are a collective effort to increase production so every nation in the world can have the doses they need.
Finally, Moderna is planning to distribute a total of 300 million doses of COVID-19 shots in the U.S. by the end of July. The delivery is projected to help President Biden achieve his goal of having the majority of American adults vaccinated by summer.
